Plain-English translation of NCT07655180 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
United States
Sponsor
Invivyd, Inc.
Enrollment target
~210 participants
Started
June 2026
Primary completion
August 2026
Age range
18 Years – 49 Years
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Study Inquiry
Invivyd, Inc.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.